Aerobiology and inhalation exposure to biological select agents and toxins

Veterinary Pathology

Volumn 47, Issue 5, 2010, Pages 779-789

  Roy, C J ^a   Reed, D S ^b   Hutt, Julie A ^c  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

aerobiology; inhalation; respiratory anatomy; respiratory immunology; select agent

Indexed keywords

TOXIN;

ANIMAL; ANIMAL MODEL; ARTICLE; BIOLOGICAL WARFARE AGENT; EXPOSURE; HUMAN; METABOLISM; MICROBIOLOGY; RESPIRATORY TRACT DISEASE;

ANIMALS; BIOLOGICAL WARFARE AGENTS; HUMANS; INHALATION EXPOSURE; MODELS, ANIMAL; RESPIRATORY TRACT DISEASES; TOXINS, BIOLOGICAL;

ANIMALIA;

EID: 78649246218     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810378650     Document Type: Article

References (74)

1. Aujla SJ, Chan YR, Zheng M., Fei M., Askew DJ, Pociask DA, Reinhart TA, McAllister F., Edeal J., Gaus K., Husain S., Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y., Kolls JK: IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med 14:275-281, 2008.
2. Bar-Haim E., Gat O., Markel G., Cohen H., Shafferman A., Velan B.: Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection. PLoS Pathog 4:e1000211, 2008.
3. Bermejo-Martin JF, Ortiz de Lejarazu R., Pumarola T., Rello J., Almansa R., Ramirez P., Martin-Loeches I., Varillas D., Gallegos MC, Seron C., Micheloud D., Gomez JM, Tenorio-Abreu A., Ramos MJ, Molina ML, Huidobro S., Sanchez E., Gordon M., Fernandez V., Del Castillo A., Marcos MA, Villanueva B., Lopez CJ, Rodriguez-Dominguez M., Galan JC, Canton R., Lietor A., Rojo S., Eiros JM, Hinojosa C., Gonzalez I., Torner N., Banner D., Leon A., Cuesta P., Rowe T., Kelvin DJ: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 13:R201, 2009.
4. Bienenstock J., McDermott MR: Bronchus- and nasal-associated lymphoid tissues. Immunol Rev 206:22-31, 2005.
5. Chand HS, Drysdale M., Lovchik J., Koehler TM, Lipscomb MF, Lyons CR: Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. Infect Immun 77:429-435, 2009.
6. Chase JC, Celli J., Bosio CM: Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis SCHU S4. Infect Immun 77:180-195, 2009.
7. Cheng YS, Irshad H., Kuehl P., Holmes TD, Sherwood R., Hobbs CH: Lung deposition of droplet aerosols in monkeys. Inhal Toxicol 20:1029-1036, 2008.
8. Clark RP, de Calcina-Goff ML: Some aspects of the airborne transmission of infection. J R Soc Interface 6:S767-S782, 2009.
9. Crowe CR, Chen K., Pociask DA, Alcorn JF, Krivich C., Enelow RI, Ross TM, Witztum JL, Kolls JK: Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 183:5301-5310, 2009.
10. Day WC, Berendt RF: Experimental tularemia in Macaca mulatta: relationship of aerosol particle size to the infectivity of airborne Pasteurella tularensis. Infect Immun 5:77-82, 1972.
11. Dembek ZF, Kortepeter MG, Pavlin JA: Discernment between deliberate and natural infectious disease outbreaks. Epidemiol Infect 135:353-371, 2007.
12. Dodd J., Riffault S., Kodituwakku JS, Hayday AC, Openshaw PJ: Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease. J Immunol 182:1174-1181, 2009.
13. Doebler JA, Wiltshire ND, Mayer TW, Estep JE, Moeller RB, Traub RK, Broomfield CA, Calamaio CA, Thompson WL, Pitt ML: The distribution of [125I]ricin in mice following aerosol inhalation exposure. Toxicology 98:137-149, 1995.
14. Druett HA, Henderson DW, Packman L., Peacock S.: Studies on respiratory infection: I. The influence of particle size on respiratory infection with anthrax spores. J Hyg (Lond) 51:359-371, 1953.
15. Druett HA, Henderson DW, Peacock S.: Studies on respiratory infection: III. Experiments with Brucella suis. J Hyg (Lond) 54:49-57, 1956.
16. Druett HA, Robinson JM, Henderson DW, Packman L., Peacock S.: Studies on respiratory infection: II. The influence of aerosol particle size on infection of the guinea-pig with Pasteurella pestis. J Hyg (Lond) 54:37-48, 1956.
17. Eitzen EM: The use of biological weapons. In: The Textbook of Military Medicine, Part 1: Medical Aspects of Chemical and Biological Weapons, ed. Zajtchuk R and Bellamy RF, pp. 437-450. Borden Institute, Washington, DC, 1997.
18. Franke-Ullmann G., Pfortner C., Walter P., Steinmuller C., Lohmann-Matthes ML, Kobzik L.: Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. J Immunol 157:3097-3104, 1996.
19. Franz D., Pitt L., Clayton M., Hanes M., Rose K.: Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism. In: Botulism and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects, ed. Dasgupta B, pp. 473-76. Springer, New York, NY, 1993.
20. Glomski IJ, Dumetz F., Jouvion G., Huerre MR, Mock M., Goossens PL: Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting. Microbes Infect 10:1398-1404, 2008.
21. Glomski IJ, Piris-Gimenez A., Huerre M., Mock M., Goossens PL: Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 3:e76, 2007.
22. Goodlow RJ, Leonard FA: Viability and infectivity of microorganisms in experimental airborne infection. Bacteriol Rev 25:182-187, 1961.
23. Gribar SC, Richardson WM, Sodhi CP, Hackam DJ: No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med 14:645-659, 2008.
24. Hahn YS, Taube C., Jin N., Sharp L., Wands JM, Aydintug MK, Lahn M., Huber SA, O'Brien RL, Gelfand EW, Born WK: Different potentials of gamma delta T cell subsets in regulating airway responsiveness: V gamma 1+ cells, but not V gamma 4+ cells, promote airway hyperreactivity, Th2 cytokines, and airway inflammation. J Immunol 172:2894-2902, 2004.
25. Harkema JR: Comparative aspects of nasal airway anatomy: relevance to inhalation toxicology. Toxicol Pathol 19:321-336, 1991.
26. Harper GJ, Morton JD: The respiratory retention of bacterial aerosols: experiments with radioactive spores. J Hyg (Lond) 51:372-385, 1953.
27. Hart MK, Pratt W., Panelo F., Tammariello R., Dertzbaugh M.: Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/ c, but not C3H/HeN mice. Vaccine 15:363-369, 1997.
28. Hartings JM, Roy CJ: The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. J Pharmacol Toxicol Methods 49:39-55, 2004.
29. Henderson RF, Driscoll KE, Harkema JR, Lindenschmidt RC, Chang IY, Maples KR, Barr EB: A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam Appl Toxicol 24:183-197, 1995.
30. Heninger S., Drysdale M., Lovchik J., Hutt J., Lipscomb MF, Koehler TM, Lyons CR: Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infect Immun 74:6067-6074, 2006.
31. Henry T., Kirimanjeswara GS, Ruby T., Jones JW, Peng K., Perret M., Ho L., Sauer JD, Iwakura Y., Metzger DW, Monack DM: Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections. J Immunol 184:3755-3767, 2010.
32. Herr C., Shaykhiev R., Bals R.: The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin Biol Ther 7:1449-1461, 2007.
33. Kirby AC, Coles MC, Kaye PM: Alveolar macrophages transport pathogens to lung draining lymph nodes. J Immunol 183:1983-1989, 2009.
34. Koohsari H., Tamaoka M., Campbell HR, Martin JG: The role of gamma delta T cells in airway epithelial injury and bronchial responsiveness after chlorine gas exposure in mice. Respir Res 8:21, 2007.
35. Kortepeter MG, Cieslak TJ, Eitzen EM: Bioterrorism. J Environ Health 63:21-24, 2001.
36. Lai KM, Burge HA, First MW: Size and UV germicidal irradiation susceptibility of Serratia marcescens when aerosolized from different suspending media. Appl Environ Microbiol 70:2021-2027, 2004.
37. Lai Y., Gallo RL: AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30:131-141, 2009.
38. Larson EW, Dominik JW, Slone TW: Aerosol stability and respiratory infectivity of Japanese B encephalitis virus. Infect Immun 30:397-401, 1980.
39. Lin Y., Ritchea S., Logar A., Slight S., Messmer M., Rangel-Moreno J., Guglani L., Alcorn JF, Strawbridge H., Park SM, Onishi R., Nyugen N., Walter MJ, Pociask D., Randall TD, Gaffen SL, Iwakura Y., Kolls JK, Khader SA: Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31:799-810, 2009.
40. Lippmann M., Schlesinger RB: Interspecies comparisons of particle deposition and mucociliary clearance in tracheobronchial airways. J Toxicol Environ Health 13:441-469, 1984.
41. Lo Re S., Dumoutier L., Couillin I., Van Vyve C., Yakoub Y., Uwambayinema F., Marien B., van den Brule S., Van Snick J., Uyttenhove C., Ryffel B., Renauld JC, Lison D., Huaux F.: IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol 184:6367-6377, 2010.
42. Lyons CR, Lovchik J., Hutt J., Lipscomb MF, Wang E., Heninger S., Berliba L., Garrison K.: Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect Immun 72:4801-4809, 2004.
43. Martonen TB, Katz IM, Musante CJ: A nonhuman primate aerosol deposition model for toxicological and pharmaceutical studies. Inhal Toxicol 13:307-324, 2001.
44. Mattix ME, Hunt RE, Wilhelmsen CL, Johnson AJ, Baze WB: Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol 23:262-268, 1995.
45. McClellan RO, Henderson RF: Concepts in Inhalation Toxicology, 2nd ed. Taylor & Francis, Washington, DC, 1995.
46. McDevitt JJ, Lai KM, Rudnick SN, Houseman EA, First MW, Milton DK: Characterization of UVC light sensitivity of vaccinia virus. Appl Environ Microbiol 73:5760-5766, 2007.
47. Mizgerd JP: Acute lower respiratory tract infection. N Engl J Med 358:716-727, 2008.
48. Owen SJ, Batzloff M., Chehrehasa F., Meedeniya A., Casart Y., Logue CA, Hirst RG, Peak IR, Mackay-Sim A., Beacham IR: Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J Infect Dis 199:1761-1770, 2009.
49. Papineni RS, Rosenthal FS: The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 10:105-116, 1997.
50. Parent RA: Comprehensive Treatise on Pulmonary Toxicology: Vol. 1. Comparative Biology of the Normal Lung. CRC Press, Inc, Boca Raton, FL, 1992.
51. Park HS, Francis KP, Yu J., Cleary PP: Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 171: 2532-2537, 2003.
52. Park JB, Simpson LL: Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component. Infect Immun 71:1147-1154, 2003.
53. Phalen R.: Inhalation Studies: Foundations and Techniques, 2nd ed. Informa Healthcare USA, Inc, New York, NY, 2009.
54. Phalen RF, Yeh HC, Schum GM, Raabe OG: Application of an idealized model to morphometry of the mammalian tracheobronchial tree. Anat Rec 190:167-176, 1978.
55. Pratt W., Hart MK, Reed DS, Steele KE: Alphaviruses. In: Biodefense: Research Methodology and Animal Models, ed. Swearengen JL, pp. 181-206. Taylor & Francis, Boca Raton, FL, 2006.
56. Quintero-Macias L., Santos-Mendoza T., Donis-Maturano L., Silva-Sanchez A., Aguilar D., Orozco H., Gicquel B., Estrada-Garcia I., Flores-Romo L., Hernandez-Pando R.: T-cell responses and in vivo cytotoxicity in the target organ and the regional lymphoid tissue during airborne infection with the virulent Mycobacterium tuberculosis MT103 and its lipid mutant fadD26. Scand J Immunol 71:20-28, 2010.
57. Roy CJ, Hale M., Hartings JM, Pitt L., Duniho S.: Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice. Inhal Toxicol 15:619-638, 2003.
58. Roy CJ, Pitt LML: Infectious disease aerobiology: aerosol challenge methods. In: Biodefense: Research Methodology and Animal Models, ed. Swearengen JL, pp. 61-76. CRC Press, Boca Raton, FL, 2005.
59. Roy CJ, Reed DS, Wilhelmsen CL, Hartings J., Norris S., Steele KE: Pathogenesis of aerosolized Eastern equine encephalitis virus infection in guinea pigs. Virol J 6:170, 2009.
60. Ryzhikov AB, Tkacheva NV, Sergeev AN, Ryabchikova EI: Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice. Biomed Sci 2:607-614, 1991.
61. Salem H., Katz SA: Inhalation Toxicology, 2nd ed. CRC Press, Boca Raton, FL, 2006.
62. Savransky V., Rostapshov V., Pinelis D., Polotsky Y., Korolev S., Komisar J., Fegeding K.: Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B. Toxicol Pathol 31:373-378, 2003.
63. Schlesinger RB: Clearance from the respiratory tract. Fundam Appl Toxicol 5:435-450, 1985.
64. Schlesinger RB: Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J Toxicol Environ Health 15:197-214, 1985.
65. Schlesinger RB, McFadden LA: Comparative morphometry of the upper bronchial tree in six mammalian species. Anat Rec 199:99-108, 1981.
66. Snipes MB: Long-term retention and clearance of particles inhaled by mammalian species. Crit Rev Toxicol 20:175-211, 1989.
67. Sorrentino R., de Souza PM, Sriskandan S., Duffin C., Paul-Clark MJ, Mitchell JA: Pattern recognition receptors and interleukin-8 mediate effects of gram-positive and gram-negative bacteria on lung epithelial cell function. Br J Pharmacol 154:864-871, 2008.
68. Steele KE, Davis KJ, Stephan K., Kell W., Vogel P., Hart MK: Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice. Vet Pathol 35:386-397, 1998.
69. Thompson GR 3rd, Patterson TF: Pulmonary aspergillosis. Semin Respir Crit Care Med 29:103-110, 2008.
70. Vogel P., Abplanalp D., Kell W., Ibrahim MS, Downs MB, Pratt WD, Davis KJ: Venezuelan equine encephalitis in BALB/c mice: kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation. Arch Pathol Lab Med 120:164-172, 1996.
71. Waldman RH, Jurgensen PF, Olsen GN, Ganguly R., Johnson JE 3rd: Immune response of the human respiratory tract: I. Immunoglobulin levels and influenza virus vaccine antibody response. J Immunol 111:38-41, 1973.
72. Weibel ER: Principles and methods for the morphometric study of the lung and other organs. Lab Invest 12:131-155, 1963.
73. Welkos SL, Keener TJ, Gibbs PH: Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 51:795-800, 1986.
74. Woolard MD, Hensley LL, Kawula TH, Frelinger JA: Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect Immun 76:2651-2659, 2008.